Short-chain fatty acids suppress inflammatory reactions in Caco-2 cells and mouse colons
The recommended starting dose is 0.25 mg per week, which can be increased to 0.5 mg per week after four weeks if tolerated
Demand Drivers: Efficacy and Bioavailability: Parenteral administration offers higher bioavailability, which is critical for the effectiveness of GLP-1 receptor agonists, particularly for the treatment of diabetes and obesity
Brady, ND, chief medical officer at Designs for Health
An editor's note in the article confirmed that Jelly Roll used a GLP-1 drug when he started working to drop the pounds, but noted, "he stopped after two weeks." So it would seem as though most of Jelly Roll's weight loss came after he tried and quit using a GLP-1
GH stimulates lipolysis (fat breakdown) specifically in visceral adipose tissue